| COVID-19 Vaccination in Pediatrics |
1 |
1 |
| COVID-19 Vaccine |
0 |
0.96 |
| COVID-19 |
0 |
0.71 |
| Vaccines |
0 |
0.67 |
| Food and Drug Administration (FDA) |
0 |
0.61 |
| Myocarditis |
0 |
0.61 |
| COVID-19 Omicron Variant |
0 |
0.5 |
| Patient Safety |
0 |
0.47 |
| Cardiomyopathy |
0 |
0.3 |
| Adolescent Medicine |
0 |
0.24 |
| Child |
0 |
0.24 |
| Immunization |
0 |
0.24 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.24 |
| Adverse Effects |
0 |
0.12 |
| Geriatrics |
0 |
0.12 |
| Hospital |
0 |
0.12 |
| Pandemic |
0 |
0.12 |
| Pericarditis |
0 |
0.12 |
| Severe Acute Respiratory Syndrome |
0 |
0.12 |
| Acute Respiratory Distress Syndrome |
0 |
0.06 |